Defining the Next Decade of BioPharma Innovation and Excellence
As Vietnam strengthens its position within Asia’s rapidly evolving life sciences landscape, BioPharma Vietnam Summit brings together the decision-makers, investors, scientists and industry leaders driving its next phase of growth.
The Summit will shape the conversations that matter most, from policy reform and capital deployment to innovation, manufacturing excellence, technology transfer and access, creating a high-level platform for the partnerships and strategic decisions that will determine Vietnam’s place in the global biopharma value chain.
Six Strategic Themes. One Biopharma Ambition.
Explore six strategic themes shaping biopharma innovation, investment, manufacturing and market growth across Vietnam and the wider region.
Pharmaceutical Manufacturing & Localisation
Strengthening domestic manufacturing capabilities through technology transfer, production scale-up, workforce development and internationally recognised quality standards.
Clinical Research & Development
Building clinical research infrastructure, trial capabilities and strategic partnerships that accelerate innovation and improve access to new therapies.
Investment, Partnerships & Ecosystem Development
Ecosystem Development Connecting industry, investors, policymakers, researchers and innovators to accelerate commercialisation, capability building and sustainable sector growth.
Vaccines, Biologics & Advanced Therapies
Advancing vaccine innovation, biologics, biosimilars, precision medicine and nextgeneration therapies that will shape the future of healthcare.
Regulatory Affairs & Market Access
Exploring the regulatory, policy and market access frameworks that enable innovation, support commercial growth and improve patient access.
Supply Chain Resilience & Distribution
Enhancing pharmaceutical supply chains, logistics networks and distribution capabilities to strengthen resilience, efficiency and long-term sustainability.
Why It Matters
The BioPharma Vietnam Summit convenes ministers, regulators, C-suite pharmaceutical and biotech leaders, investors, research pioneers and healthcare decision-makers to shape the priorities defining Vietnam’s next phase of biopharma revolution.
Through high-level debate, the Summit will address regulatory transformation, capital deployment, R&D, technology transfer, advanced manufacturing, supply resilience and market access, aligning public and private leadership around the decisions that will expand patient care.
Who Takes the Stage
-
Global pharmaceutical and biotech leaders driving investment, innovation and market expansion.
-
Policymakers, regulators and industry associations advancing the frameworks that support industry growth and patient access.
-
Manufacturing and quality leaders strengthening production capability, technology transfer and operational excellence.
-
Clinical research and healthcare leaders accelerating trial readiness, collaboration and evidence generation.
-
Biologics and advanced therapies innovators developing the next generation of vaccines, biologics and precision therapies.
-
Investors and strategic partners supporting commercialisation, partnerships and ecosystem development.
-
Academic and research institutions connecting scientific discovery with real-world impact.
-
Supply chain and market access experts enabling access, resilience and growth across global markets.
Shape The Agenda
Help shape the conversations driving Vietnam's biopharma future.
We are looking for speakers who can share practical experience, strategic insight and real-world case studies across manufacturing, clinical research, innovation, regulation, market access, investment and partnerships.
We welcome submissions from industry leaders, researchers, investors, policymakers and solution providers with expertise relevant to Vietnam and global life sciences markets.
Interested in speaking? Visit our Call for Speakers page to submit your proposal.
